AVAH at a glance
Aveanna Healthcare Holdings, Inc. (AVAH, SEC CIK 1832332) filed its latest 10-K annual report on March 19, 2026, a 10-Q quarterly report on November 12, 2026, an 8-K current report on November 13, 2026 and Form 4 insider filings as recently as October 5, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.
- For the fiscal year ended January 3, 2026 (FY2025), Aveanna Healthcare Holdings, Inc. (AVAH) reported revenue of $2.4 billion (up 20.2% from FY2024) and net income of $225.0 million. Diluted EPS was $1.05.
- As of September 30, 2026, 30 institutional investment managers tracked by SignalX reported holding Aveanna Healthcare Holdings, Inc. (AVAH) shares worth $503.6 million in 13F-HR filings.
- The most recent insider open-market sale reported on Form 4 was by VIGANO PAUL R on August 21, 2026 of 2,250,000 shares at $11.50 per share.
Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).
- Revenue · FY2025
- $2.4B
- +20.2% vs prior year
- Insiders · 90 days
- 0 buys · 0 sells
- No open-market trades
- 13F holders
- 30 funds
- $503.6M · +0 vs prior quarter
- Latest 8-K
- Nov 13, 2026
- Item 7.01
AI 10-Q Quarterly Report Analysis
Latest 10-Q, quarter ended Oct 3, 2026
Management Discussion & Analysis
- Q3 revenue $695.5M, up 11.8% YoY from $621.9M
- Operating margin 12.0% vs 8.6% YoY, gross margin 32.6% vs 32.6%
- Best segment HHH: revenue $72.1M, up 15.6%; worst growth MS: revenue $49.2M, up 9.1%
- Operating cash flow $157.5M, up from $76.1M; investing outflow $188.7M, driven by Family First acquisition
- Cash $197.8M, with $68.7M securitization capacity and approximately $225.6M revolver capacity; liquidity sufficient for at least twelve months
Risk Factors
- No material changes to 10-K risk factors for fiscal year ended January 3, 2026
- Carried-forward risks include regulatory compliance, reimbursement changes, and healthcare litigation
- Ongoing operational exposure to labor shortages and employee retention
- Continued financial sensitivity to liquidity, debt obligations, and reimbursement timing
AI summary of the AVAH 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K
AI 8-K Current Report Analysis
The most recent material events, by 8-K item
Item 7.01: Regulation FD Disclosure
- Aveanna released an investor financial presentation on November 13, 2026, potentially updating operating and financial outlook
- Exhibit 99.1 contains the substantive presentation, requiring review for guidance, results, and strategic updates
Item EX-99.1: Item EX-99.1
- November 2026 presentation raises 2026 guidance above $2.695B revenue and $374M Adjusted EBITDA
- Q3 revenue $695.5M, up 11.8%, while Adjusted EBITDA reached $100.1M, up 25.0%
Item 7.01: Regulation FD Disclosure
- Item 7.01 incorporates Item 2.02 information, indicating earnings-related disclosure for Aveanna Healthcare
- Investor-relevant details reside in Item 2.02 and its accompanying exhibit
Item 2.02: Results of Operations and Financial Condition
- Press release announces Aveanna’s financial results for the three and nine months ended October 3, 2026
- Investors should review Exhibit 99.1 for revenue, profitability, cash flow and guidance details
Item EX-99.1: Item EX-99.1
- Q3 revenue $695.5M, up 11.8%, with growth across PDS, HHH and MS segments
- Net income $45.5M versus $14.1M, while diluted EPS increased to $0.20 from $0.06
Item 5.02: Departure/Appointment of Directors or Principal Officers
- Steven E. Rodgers resigned immediately on October 1, 2026 as a Class II independent director
- Departure affects Board oversight of Audit and Compensation Committees
AI summaries of AVAH 8-K current reports filed with the SEC. What 8-K item codes mean
SignalX for AVAH
Don't miss the next AVAH filing
- Alerts as it files. A push when AVAH files an 8-K or an insider trades.
- Fund moves. Which tracked funds opened, added or cut AVAH, by share count.
- Ask anything. An AI agent that reads every AVAH filing and answers with sources.
Recent Insider Transactions (Form 4)
Latest reported trades by officers, directors and 10% owners
| Insider | Type | Date | Shares | Price |
|---|---|---|---|---|
| Stewart Deborah | A | Oct 1, 2026 | 75,000 | - |
| VIGANO PAUL R | Sell | Aug 21, 2026 | 2,250,000 | $11.50 |
| WILLIAMS ROBERT M JR | Sell | Aug 21, 2026 | 2,250,000 | $11.50 |
| J.H. Whitney Equity Partners VII, LLC | Sell | Aug 21, 2026 | 2,250,000 | $11.50 |
| Windley Rodney D | Sell | Aug 20, 2026 | 180,000 | $11.50 |
| WILLIAMS ROBERT M JR | Sell | Aug 20, 2026 | 957,918 | $11.50 |
| Shaner Jeff | Sell | Aug 20, 2026 | 90,000 | $11.50 |
| VIGANO PAUL R | Sell | Aug 20, 2026 | 957,918 | $11.50 |
Financial SummaryXBRL
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Profitability | |||
| Revenue | - | $2.0B | $2.4B |
| Gross Profit | $595.4M | $635.5M | $810.5M |
| Operating Income | $8.1M | $139.8M | $256.5M |
| Net Income | - | -$10.9M | $225.0M |
| Gross Margin | - | 31.4% | 33.3% |
| Op. Margin | - | 6.9% | 10.5% |
| Net Margin | - | -0.5% | 9.2% |
| Balance Sheet | |||
| Total Assets | $1.6B | $1.7B | $2.0B |
| Equity | - | -$123.6M | $194.5M |
| ROE | - | 8.8% | 115.7% |
| Per Share | |||
| EPS | $-0.71 | $-0.06 | $1.05 |
| Cash Flow | |||
| Operating CF | - | $32.6M | $125.9M |
Source: XBRL data in Aveanna Healthcare Holdings, Inc. (AVAH)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →
13F Fund Holdings: Quarterly Trend
Latest: Q3 2026Aggregate AVAH share value held by 13F filers tracked by SignalX, by quarter.
Quarterly totals table
| Quarter | Funds | Total value |
|---|---|---|
| Q3 2026 | 30 | $503.6M |
| Q2 2026 | 30 | $272.6M |
| Q1 2026 | 32 | $147.7M |
| Q4 2025 | 26 | $188.6M |
| Q3 2025 | 25 | $142.5M |
| Q2 2025 | 25 | $64.3M |
| Q1 2025 | 20 | $33.2M |
| Q4 2024 | 16 | $25.0M |
- Dimensional Fund Advisors+1.25M (+56%)
- Vanguard Capital Management LLC+1.23M (+34%)
- Two Sigma Investments+988.8K (+83%)
- BlackRock+855.1K (+12%)
- Citadel Advisors LLC+753.0K (+33%)
- Goldman Sachs Group−360.4K (-41%)
- Raymond James Financial−278.1K (-24%)
- Prudential Financial−32.6K (-9%)
- Millennium Management+2.87M
- U.S. Bancorp+59
- FMR LLC (Fidelity)−1.54M
- Mangrove Partners−47.3K
Source: 13F-HR filings on SEC EDGAR (aggregated from 204 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work
AVAH filing archive
AI analysis pages for each 10-K, 10-Q and 8-K
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
| Form | Filing date | Period | Analysis | SEC |
|---|---|---|---|---|
| 8-K | Nov 13, 2026 | - | Analysis | - |
| 10-Q | Nov 12, 2026 | Oct 3, 2026 | Analysis | |
| 8-K | Nov 12, 2026 | - | Analysis | - |
| 4 | Oct 5, 2026 | - | - | - |
| 8-K | Oct 2, 2026 | - | Analysis | - |
| 8-K | Aug 24, 2026 | - | Analysis | - |
| 4 | Aug 24, 2026 | - | - | - |
| 4 | Aug 24, 2026 | - | - | - |
| 4 | Aug 24, 2026 | - | - | - |
| 4 | Aug 24, 2026 | - | - | - |
| 4 | Aug 24, 2026 | - | - | - |
| 4 | Aug 24, 2026 | - | - | - |
| 8-K | Aug 13, 2026 | - | Analysis | - |
| 8-K | Aug 13, 2026 | - | Analysis | - |
| 10-Q | Aug 13, 2026 | Jul 4, 2026 | Analysis | |
| 8-K | Aug 7, 2026 | - | Analysis | - |
| 4 | Jul 2, 2026 | - | - | - |
| 4 | Jul 2, 2026 | - | - | - |
| 4 | Jul 2, 2026 | - | - | - |
| 4 | Jun 26, 2026 | - | - | - |
| 4 | Jun 26, 2026 | - | - | - |
| 4 | Jun 26, 2026 | - | - | - |
| 4 | Jun 5, 2026 | - | - | |
| 4 | Jun 5, 2026 | - | - | |
| 4 | Jun 5, 2026 | - | - |
Related Health Care companies
- AHCO · AdaptHealth Corp.Services-Home Health Care Services
- ADUS · Addus HomeCare CorpServices-Home Health Care Services
- BTSG · BrightSpring Health Services, Inc.Services-Home Health Care Services
- CHE · Chemed CorpServices-Home Health Care Services
- EHAB · Enhabit, Inc.Services-Home Health Care Services
- OPCH · Option Care Health, Inc.Services-Home Health Care Services
- TXG · 10x Genomics, Inc.Laboratory Analytical Instruments
- FDMT · 4D Molecular Therapeutics, Inc.Biological Products, (No Diagnostic Substances)
AVAH SEC filings: frequently asked questions
Which institutions hold AVAH stock?
As of September 30, 2026, the largest Aveanna Healthcare Holdings, Inc. (AVAH) holders among the 13F filers tracked by SignalX were BlackRock ($102.6 million), Vanguard Capital Management LLC ($60.9 million), Dimensional Fund Advisors ($43.6 million), Citadel Advisors LLC ($37.7 million), Millennium Management ($35.7 million). 13F-HR reports are filed up to 45 days after each quarter ends.
What was AVAH's revenue in fiscal year 2025?
For the fiscal year ended January 3, 2026 (FY2025), Aveanna Healthcare Holdings, Inc. (AVAH) reported revenue of $2.4 billion (up 20.2% from FY2024) and net income of $225.0 million. Diluted EPS was $1.05. The figures come from the XBRL data in the 10-K.
What did AVAH report in its latest 8-K?
Aveanna Healthcare Holdings, Inc. (AVAH) filed an 8-K on November 13, 2026 reporting Item 7.01 (Regulation FD Disclosure). Aveanna released an investor financial presentation on November 13, 2026, potentially updating operating and financial outlook.
What are the latest AVAH SEC filings?
Aveanna Healthcare Holdings, Inc. (AVAH) filed its latest 10-K annual report on March 19, 2026, a 10-Q quarterly report on November 12, 2026, an 8-K current report on November 13, 2026 and a Form 4 insider filing on October 5, 2026.
What is AVAH's SEC CIK number?
Aveanna Healthcare Holdings, Inc. (AVAH)'s SEC Central Index Key (CIK) is 1832332. EDGAR lists every AVAH filing under that number.
Ask anything about AVAH
The research agent reads AVAH's filings, financials, insider trades and 13F holders, then answers with sources.